Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 02 symbols : AZNCF save search
New Drug Delivery Systems Market 2022-2026 | Rising Prevalence Of Chronic Diseases to Boost Growth | Technavio
Published: 2022-03-02 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -6.92%
H: 1.86%
C: 1.86%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MDT | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
|
| O: 0.28%
H: 0.54%
C: -0.33%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -2.63%
H: 0.9%
C: -0.3%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 2.3%
H: 0.0%
C: 0.0%
new drug drug liver system disease growth drug delivery
Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published: 2022-03-02 (Crawled : 14:00) - biospace.com/
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
GNPX | $2.16 -2.26% -2.31% 17K
|
Health Technology
|
| O: 3.95%
H: 5.06%
C: -7.17%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
tagrisso gene therapy trial cel lung cancer phase 1 therapy cancer
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.